Navigation Links
ViaCyte Names Michael Scott Vice President, Device Research & Development
Date:6/15/2011

SAN DIEGO, June 15, 2011 /PRNewswire/ -- ViaCyte, Inc. today announced the appointment of Michael J. Scott, Ph.D. as Vice President, Device Research and Development, reporting to John West, President and Chief Executive Officer.  In this capacity, Dr. Scott will oversee all device development and manufacturing activities, including design, engineering, and testing.  Dr. Scott will also contribute to regulatory matters in the device area and to the overall leadership and strategic direction of the Company.

"We are pleased to have Mike join ViaCyte.  He has a successful track record of leading complex device development projects, from technical innovation through clinical implementation," said Mr. West.  "We expect Mike's experience with implantable medical devices, together with our stem cell expertise, will effectively advance our combination product toward regulatory approval."

Before joining ViaCyte, Dr. Scott served in multiple managerial positions at Edwards Lifesciences, a publically traded company focused on the science of heart valves and hemodynamic monitoring.  Dr. Scott's most recent role was Senior Director of Engineering, Heart Valve Therapies, in which he managed high profile products that are currently in preclinical and clinical trial phases with commercialization expected later this year.  Dr. Scott also served as the Technical Team Leader for a bioprosthetic heart valve which is currently the best selling product of its type worldwide, generating over $100 million in annual revenue.

Dr. Scott's past experience also includes the role of Vice President of Research and Development at Orqis Medical Corporation, a venture-backed medical device startup.  Dr. Scott led Orqis to the first human use of a sophisticated implantable blood pump system for the treatment of congestive heart failure.  His broad range of responsibilities also included the oversight of system design and development, in vivo studies, and the product development pipeline.  He found the early-stage entrepreneurial environment at Orqis to be professionally rewarding and this experience will transfer to his work at ViaCyte.  Dr. Scott was educated in Canada, earning a Ph.D. in medical biophysics from the University of Western Ontario, and a B.A.Sc. and an M.A.Sc. in civil engineering from the University of Waterloo in Ontario.

"ViaCyte presents a tremendous opportunity to address an unmet need in diabetes," said Dr. Scott.  "I'm excited to be part of a team widely recognized for its scientific leadership in this area, and I look forward to applying my implantable device experience toward this worldwide medical problem."

About ViaCyte

ViaCyte is a preclinical cell therapy company focused on diabetes.  The Company's technology is based on pancreatic beta cell progenitors derived from human pluripotent stem cells.  These cells are implanted using a durable and retrievable encapsulation device.  Once implanted and matured, these cells secrete insulin in response to blood glucose levels.  ViaCyte's goal is long term insulin independence without immune suppression, and without hypoglycemia and other diabetes-related complications.

ViaCyte is a private company headquartered in San Diego, California, with additional operations in Athens, Georgia.  The Company is funded in part by the California Institute for Regenerative Medicine.

This news release may contain forward-looking statements made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995.


'/>"/>
SOURCE ViaCyte, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Novocell Becomes ViaCyte, Inc., as it Accelerates Pre-Clinical Development of a Stem Cell Derived Treatment for Diabetes
2. ViaCyte, Inc., Receives Three Additional U.S. Patents, Supporting its Development of a Stem Cell Derived Treatment for Diabetes
3. PreXion, Inc. Names Visionary Industry Leader, Motoaki Saito, M.D., Ph.D. as CEO
4. Olympus Biotech Names Oliver Burckhardt to President North America
5. Delcath Names Harold C. Mapes as Executive Vice President of Global Operations
6. Savient Pharmaceuticals Names Seasoned Pharma Exec Richard Crowley EVP Biopharmaceutical Operations
7. NxStage® Names Michael Miller, Jr. President, International
8. Cetero Research Names 25-Year Industry Veteran James Dixon to Head Quality and Compliance
9. BridgePoint Medical Names Industry Veteran as Chief Executive Officer
10. Survey Sampling International Names Chris DeAngelis to Head New SSI Health
11. NAFE Names Lilly to Top 50 Companies for Executive Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...   Bay Area Lyme Foundation , collaborating ... for Tick Borne Illness , Harvard Medical School ... Medicine, University of California, Berkeley, and the Veterans ... finalists of Lyme Innovation , the first ... scientists, clinicians, researchers, entrepreneurs, and investors from several ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016 /PRNewswire/ ... pulmonary function testing company, is now able to perform sophisticated lung ... ndd Medical Technologies , Inc. Patients are ... labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients like ... any needed testing done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
Breaking Medicine Technology:
(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A ... 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the ... history as home to some of the world’s leading providers of cereal and other ...
(Date:6/26/2016)... ... , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a ... fitness app plans to fix the two major problems leading the fitness industry today:, ... type program , They don’t eliminate all the reasons people quit their exercise ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
Breaking Medicine News(10 mins):